Animal Parasiticide Market: Market Size & Forecast 2026

The animal parasiticide market comprises pharmaceutical products designed to prevent and treat parasitic infections in livestock, poultry, and companion animals. With a 2025 valuation of approximately $11.1 billion, the market is on a trajectory to reach between $17.5 billion and $17.9 billion by 2030-2031, depending on the forecasting source. Product categories include endoparasiticides for internal worms, ectoparasiticides for external fleas and ticks, and endectocides that address both parasite types.

• •Market valued at ~$11.1 billion in 2025 with 6.54% CAGR
• •Projected to reach $17.5-17.9 billion by 2030-2031
• •Three main product categories: endoparasiticides, ectoparasiticides, and endectocides

Increasing global demand for animal protein is expanding the livestock sector, driving higher consumption of parasiticides to maintain herd health and productivity. Rising pet ownership and the humanization of companion animals, particularly in developed and emerging markets, are boosting demand for premium parasite control products. Additionally, growing concerns about zoonotic diseases transmitted between animals and humans are prompting stricter parasite management protocols in both agricultural and domestic settings.

• •Expanding global meat and dairy consumption driving livestock parasite control demand
• •Rising companion animal ownership and pet care spending
• •Increased focus on zoonotic disease prevention and food safety standards

The market is segmented by product type into endoparasiticides, ectoparasiticides, and endectocides, with endectocides gaining share due to their broad-spectrum efficacy. By animal type, the market serves both food-producing animals (cattle, sheep, pigs, poultry) and companion animals (dogs, cats), with companion animal products often commanding higher margins. Geographically, North America and Europe currently lead in market share due to high pet ownership rates and stringent animal health regulations, while Asia-Pacific is expected to see the fastest growth driven by expanding livestock sectors and rising disposable incomes.

• •Endectocides growing due to broad-spectrum convenience and efficacy
• •Companion animal segment growing faster than livestock segment
• •Asia-Pacific projected as the fastest-growing regional market

What are the recent trends and outlook?

The market is experiencing a shift toward combination products and longer-duration formulations that reduce application frequency and improve compliance. Increasing regulatory scrutiny and the phase-out of certain chemical classes are driving innovation toward novel active ingredients and biological alternatives. As the market approaches $18 billion by the early 2030s, growth will likely be sustained by emerging market expansion, continued companion animal humanization, and the ongoing need to combat antiparasitic resistance.

• •Growing preference for long-acting and combination parasiticide formulations
• •Regulatory pressures and resistance management driving new product development
• •Emerging markets and companion animal care to remain key growth vectors through 2030s